Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Paeds SAQsgastroenterology-hepatology-and-nutrition

Paeds SAQs · gastroenterology-hepatology-and-nutrition

Ascites and peritoneal disease: SAQ

Short-answer questions on ascites and peritoneal disease in children covering an eight-year-old with biliary atresia who develops fever and abdominal pain over established ascites, the diagnostic paracentesis and spontaneous bacterial peritonitis threshold, the albumin-based management of SBP, and the stepwise management of cirrhotic ascites including the serum-ascites albumin gradient.

20 marks30 min
On this page & tools

Target exams

RACP DWEMRCPCH TheoryABP General Pediatrics

Target exams

RACP DWEMRCPCH TheoryABP General Pediatrics
Prompt
An eight-year-old boy with biliary atresia who had a Kasai portoenterostomy in infancy is admitted with a one-day history of fever, abdominal pain, and increasing drowsiness. He has known chronic liver disease with tense ascites. On examination his temperature is 38.8 degrees Celsius, he is drowsy but rousable, and his abdomen is distended with shifting dullness and diffuse tenderness. His blood pressure is 95 over 60 mmHg, heart rate is 120 beats per minute, and his capillary refill is 3 seconds. A diagnostic paracentesis is performed and the ascitic fluid polymorphonuclear count is 480 per cubic millimetre. His serum albumin is 24 g per litre and his ascitic albumin is 8 g per litre.

This boy with known biliary atresia and chronic liver disease presents the classic picture of spontaneous bacterial peritonitis complicating cirrhotic ascites. The fever, abdominal pain, and increasing drowsiness in a cirrhotic child with ascites are the cardinal triggers for SBP, and they should never be attributed to a minor viral illness without a diagnostic paracentesis. The ascitic polymorphonuclear count of 480 per cubic millimetre is above the diagnostic threshold of 250 per cubic millimetre and confirms the diagnosis. The serum-ascites albumin gradient of 16 g per litre, calculated as 24 minus 8, confirms that the ascites is portal-hypertensive and therefore cirrhotic in origin. [1]

Question 1 (10 marks)

Outline your immediate management of this child, including the diagnosis, antibiotic therapy, and the role of albumin. [1]

The diagnosis is spontaneous bacterial peritonitis, made by the ascitic fluid polymorphonuclear count of 250 or more per cubic millimetre. The diagnostic paracentesis has already been performed, and the result of 480 per cubic millimetre is diagnostic regardless of the culture result, which may take days to return. The child should not wait for the culture before treatment is started, because delay increases mortality. [1]

Empirical antibiotic therapy is begun immediately with a third-generation cephalosporin. Cefotaxime or ceftriaxone at 50 to 100 mg per kg per day covers the typical enteric organisms that translocate from the cirrhotic gut, and it is continued for 5 to 7 days, guided by the clinical response and the culture and sensitivity results when they return. The fever, tachycardia, and prolonged capillary refill indicate early circulatory compromise, so intravenous access is secured and fluid resuscitation is given judiciously, because the cirrhotic child tolerates both overfilling and underfilling poorly. [1]

Intravenous albumin is a critical adjunct, not an optional extra. The landmark randomised trial by Sort and colleagues demonstrated that albumin at 1.5 g per kg on day 1 and 1 g per kg on day 3 reduces the incidence of hepatorenal syndrome and improves survival in SBP. The mechanism is expansion of the effective circulating volume and restoration of oncotic pressure in a child whose splanchnic vasodilation has reduced the effective arterial blood volume. The child's renal function and urine output are monitored closely, because hepatorenal syndrome is the feared renal complication. [2]

The paediatric hepatology and intensive care teams are involved early, because SBP carries a one-year mortality of 50 to 70 per cent and is an independent indication for liver transplant assessment. The family is counselled honestly about the seriousness of the event and the need for transplantation as the definitive treatment. After recovery, secondary prophylaxis is commenced. [2]

Question 2 (10 marks)

Describe how you would calculate and interpret the serum-ascites albumin gradient in this child, and outline the stepwise management of his cirrhotic ascites after recovery from SBP, including secondary prophylaxis. [1]

The serum-ascites albumin gradient is calculated by subtracting the ascitic fluid albumin from the serum albumin, both measured on the same day. In this child it is 24 minus 8, giving a gradient of 16 g per litre. A gradient of 11 g per litre or more indicates portal hypertension, and a gradient under 11 g per litre indicates a non-portal cause. This child's gradient of 16 g per litre confirms portal-hypertensive, cirrhotic ascites, consistent with his biliary atresia. The gradient is superior to the old transudate-exudate concept because it correctly classifies the cause in over 97 per cent of cases. [1]

The stepwise management of cirrhotic ascites begins with dietary sodium restriction to 1 to 2 mmol per kg per day, combined with advice against added salt and processed foods. Fluid restriction is reserved for the child with dilutional hyponatraemia. The first-line diuretic is spironolactone at 1 to 3 mg per kg per day, with furosemide at 0.5 to 1 mg per kg per day added to maintain normokalaemia and increase the natriuretic response. The target weight loss is no more than 0.5 kg per day, because faster diuresis risks intravascular depletion and hepatorenal syndrome. [1]

For tense or refractory ascites, large-volume paracentesis is performed. When more than 5 litres is drained, albumin is given at 6 to 8 g per litre of fluid removed to prevent paracentesis-induced circulatory dysfunction, which otherwise precipitates hepatorenal syndrome and shortens survival. Refractory ascites is managed with serial paracentesis or a transjugular intrahepatic portosystemic shunt, and it is a firm indication for liver transplant assessment. [1]

After a first episode of SBP, secondary prophylaxis with an oral quinolone such as norfloxacin, or with trimethoprim-sulfamethoxazole, is continued indefinitely until transplantation. A meta-analysis of randomised trials confirmed that quinolone prophylaxis reduces the recurrence of SBP and may reduce mortality in high-risk cirrhotic patients. This child should therefore be commenced on secondary prophylaxis and referred for urgent transplant assessment. [3]

References

  1. [1]Runyon BA, AASLD Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology, 2013.PMID 23463403
  2. [2]Sort P, Navasa M, Arroyo V, et al Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med, 1999.PMID 10432325
  3. [3]Malvi A, Verma N, Khatib MN, et al Impact of Quinolone Prophylaxis on Spontaneous Bacterial Peritonitis and Mortality in Cirrhosis Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. JGH Open, 2025.PMID 40247847